Prot #GS-US-546-5857: A Phase 3, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination with Azacitidine versus Physician's Choice of Venetoclax in Combination with Azacitidine or Intensive Chemotherapy in Previously

Project: Research project

Project Details

Effective start/end date1/10/221/10/25


  • Pharmaceutical Research Associates, Inc. (Prot #GS-US-546-5857 Amend #1)
  • Gilead Sciences, Inc. (Prot #GS-US-546-5857 Amend #1)